Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Nivolumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 24 Carcinoma, Renal Cell 18 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 11 Neoplasm Metastasis 10 Stomach Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Hepatocellular 7 Adenocarcinoma Of Esophagus 7 Skin Neoplasms 6 Neoplasms 6 Carcinoma, Transitional Cell 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Merkel Cell 4 Brain Neoplasms 4 Urethral Neoplasms 3 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Lymphoma, Non-Hodgkin 3 Liver Neoplasms 3 Hodgkin Disease 3

Interventions

Carboplatin 4 Paclitaxel 3 Bevacizumab 3 trastuzumab deruxtecan 1 rucaparib 1 pembrolizumab 1 olaparib 1 niraparib 1 mirvetuximab soravtansine 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Hyperthermic Intraperitoneal Chemotherapy 1 Glucose 1 GEN-1 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡